Literature DB >> 29485268

Binding Mode Characterization and Early in Vivo Evaluation of Fragment-Like Thiols as Inhibitors of the Virulence Factor LasB from Pseudomonas aeruginosa.

Andreas M Kany1, Asfandyar Sikandar2, Jörg Haupenthal1, Samir Yahiaoui1, Christine K Maurer1, Ewgenij Proschak3, Jesko Köhnke2, Rolf W Hartmann1,4.   

Abstract

The increasing emergence of antibiotic resistance necessitates the development of anti-infectives with novel modes of action. Targeting bacterial virulence is considered a promising approach to develop novel antibiotics with reduced selection pressure. The extracellular collagenase elastase (LasB) plays a pivotal role in the infection process of Pseudomonas aeruginosa and therefore represents an attractive antivirulence target. Mercaptoacetamide-based thiols have been reported to inhibit LasB as well as collagenases from clostridia and bacillus species. The present work provides an insight into the structure-activity relationship (SAR) of these fragment-like LasB inhibitors, demonstrating an inverse activity profile compared to similar inhibitors of clostridial collagenase H (ColH). An X-ray cocrystal structure is presented, revealing distinct binding of two compounds to the active site of LasB, which unexpectedly maintains an open conformation. We further demonstrate in vivo efficacy in a Galleria mellonella infection model and high selectivity of the LasB inhibitors toward human matrix metalloproteinases (MMPs).

Entities:  

Keywords:  Galleria mellonella; LasB; antibiotic resistance; antivirulence agent; binding mode; elastase; selectivity

Mesh:

Substances:

Year:  2018        PMID: 29485268     DOI: 10.1021/acsinfecdis.8b00010

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  12 in total

Review 1.  Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance.

Authors:  Chongbing Liao; Xin Huang; Qingxia Wang; Dan Yao; Wuyuan Lu
Journal:  Front Cell Infect Microbiol       Date:  2022-07-06       Impact factor: 6.073

2.  Inhibition of Collagenase Q1 of Bacillus cereus as a Novel Antivirulence Strategy for the Treatment of Skin-Wound Infections.

Authors:  Alaa Alhayek; Essak S Khan; Esther Schönauer; Tobias Däinghaus; Roya Shafiei; Katrin Voos; Mitchell K L Han; Christian Ducho; Gernot Posselt; Silja Wessler; Hans Brandstetter; Jörg Haupenthal; Aránzazu Del Campo; Anna K H Hirsch
Journal:  Adv Ther (Weinh)       Date:  2022-01-15

3.  Substrate-Inspired Fragment Merging and Growing Affords Efficacious LasB Inhibitors.

Authors:  Cansu Kaya; Isabell Walter; Samir Yahiaoui; Asfandyar Sikandar; Alaa Alhayek; Jelena Konstantinović; Andreas M Kany; Jörg Haupenthal; Jesko Köhnke; Rolf W Hartmann; Anna K H Hirsch
Journal:  Angew Chem Int Ed Engl       Date:  2021-12-13       Impact factor: 16.823

4.  Structural Requirements of N-alpha-Mercaptoacetyl Dipeptide (NAMdP) Inhibitors of Pseudomonas Aeruginosa Virulence Factor LasB: 3D-QSAR, Molecular Docking, and Interaction Fingerprint Studies.

Authors:  José Luis Velázquez-Libera; Juliana Andrea Murillo-López; Alexander F de la Torre; Julio Caballero
Journal:  Int J Mol Sci       Date:  2019-12-05       Impact factor: 5.923

5.  N-Aryl-3-mercaptosuccinimides as Antivirulence Agents Targeting Pseudomonas aeruginosa Elastase and Clostridium Collagenases.

Authors:  Jelena Konstantinović; Samir Yahiaoui; Alaa Alhayek; Jörg Haupenthal; Esther Schönauer; Anastasia Andreas; Andreas M Kany; Rolf Müller; Jesko Koehnke; Fabian K Berger; Markus Bischoff; Rolf W Hartmann; Hans Brandstetter; Anna K H Hirsch
Journal:  J Med Chem       Date:  2020-06-17       Impact factor: 7.446

6.  An In Vitro Cell Culture Model for Pyoverdine-Mediated Virulence.

Authors:  Donghoon Kang; Natalia V Kirienko
Journal:  Pathogens       Date:  2020-12-24

7.  N-Aryl mercaptoacetamides as potential multi-target inhibitors of metallo-β-lactamases (MBLs) and the virulence factor LasB from Pseudomonas aeruginosa.

Authors:  Samir Yahiaoui; Katrin Voos; Jörg Haupenthal; Thomas A Wichelhaus; Denia Frank; Lilia Weizel; Marco Rotter; Steffen Brunst; Jan S Kramer; Ewgenij Proschak; Christian Ducho; Anna K H Hirsch
Journal:  RSC Med Chem       Date:  2021-07-29

Review 8.  Using Structure-guided Fragment-Based Drug Discovery to Target Pseudomonas aeruginosa Infections in Cystic Fibrosis.

Authors:  Sheikh Mohammed Arif; R Andres Floto; Tom L Blundell
Journal:  Front Mol Biosci       Date:  2022-03-30

Review 9.  High-Throughput Approaches for the Identification of Pseudomonas aeruginosa Antivirulents.

Authors:  Donghoon Kang; Liyang Zhang; Natalia V Kirienko
Journal:  mBio       Date:  2021-05-04       Impact factor: 7.867

10.  Phosphonate as a Stable Zinc-Binding Group for "Pathoblocker" Inhibitors of Clostridial Collagenase H (ColH).

Authors:  Katrin Voos; Esther Schönauer; Alaa Alhayek; Jörg Haupenthal; Anastasia Andreas; Rolf Müller; Rolf W Hartmann; Hans Brandstetter; Anna K H Hirsch; Christian Ducho
Journal:  ChemMedChem       Date:  2021-03-16       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.